Literature DB >> 20225012

Rodent models of varicella-zoster virus neurotropism.

Jeffrey I Cohen1.   

Abstract

Inoculation of rodents with varicella-zoster virus (VZV) results in a latent infection in dorsal root ganglia with expression of at least five of the six VZV transcripts and one of the viral proteins that are reported to be expressed during latency in human ganglia. Rats develop allodynia and hyperalgesia in the limb distal to the site of injection and the resulting exaggerated withdrawal response to stimuli is reduced by treatment with gabapentin and amitryptyline, but not by antiviral therapy. Inoculation of rats with VZV mutants show that most viral genes are dispensable for latency, but that some genes (e.g., ORF4, 29, and ORF63) that are expressed during latency are important for the establishment of latency in rodents, but not for infection of rodent ganglia. The rodent model for VZV latency allows one to study ganglia removed immediately after death, avoiding the possibility of reactivation, and helps to identify VZV genes required for latency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20225012      PMCID: PMC3410751          DOI: 10.1007/82_2010_11

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  53 in total

1.  Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs.

Authors:  F S Hasnie; J Breuer; S Parker; V Wallace; J Blackbeard; I Lever; P R Kinchington; A H Dickenson; T Pheby; A S C Rice
Journal:  Neuroscience       Date:  2006-12-29       Impact factor: 3.590

2.  Varicella-Zoster virus gene expression at variable periods following death in a rat model of ganglionic infection.

Authors:  Esther Grinfeld; Roslyn Goodwin; Peter G E Kennedy
Journal:  Virus Genes       Date:  2006-10-13       Impact factor: 2.332

3.  Absence or overexpression of the Varicella-Zoster Virus (VZV) ORF29 latency-associated protein impairs late gene expression and reduces VZV latency in a rodent model.

Authors:  Jeffrey I Cohen; Tammy Krogmann; Lesley Pesnicak; Mir A Ali
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

4.  Downregulation of varicella-zoster virus (VZV) immediate-early ORF62 transcription by VZV ORF63 correlates with virus replication in vitro and with latency.

Authors:  Susan E Hoover; Randall J Cohrs; Zoila G Rangel; Donald H Gilden; Peter Munson; Jeffrey I Cohen
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain.

Authors:  Stephen J Medhurst; Sue D Collins; Andy Billinton; Sharon Bingham; Robert G Dalziel; Amanda Brass; Jennifer C Roberts; Andrew D Medhurst; Iain P Chessell
Journal:  Pain       Date:  2007-12-31       Impact factor: 6.961

6.  Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts.

Authors:  Stefan L Oliver; Leigh Zerboni; Marvin Sommer; Jaya Rajamani; Ann M Arvin
Journal:  J Virol Methods       Date:  2008-09-24       Impact factor: 2.014

7.  The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy.

Authors:  V C J Wallace; A R Segerdahl; D M Lambert; S Vandevoorde; J Blackbeard; T Pheby; F Hasnie; A S C Rice
Journal:  Br J Pharmacol       Date:  2007-06-11       Impact factor: 8.739

8.  Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system.

Authors:  Zhen Zhang; Jenny Rowe; Weijia Wang; Marvin Sommer; Ann Arvin; Jennifer Moffat; Hua Zhu
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

9.  Varicella-Zoster virus IE63, a major viral latency protein, is required to inhibit the alpha interferon-induced antiviral response.

Authors:  Aruna P N Ambagala; Jeffrey I Cohen
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

10.  Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread.

Authors:  Qingxue Li; Mir A Ali; Jeffrey I Cohen
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

View more
  7 in total

1.  Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Varicella zoster virus latency.

Authors:  Emily Eshleman; Aamir Shahzad; Randall J Cohrs
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

3.  Neuronal changes induced by Varicella Zoster Virus in a rat model of postherpetic neuralgia.

Authors:  Jean-Marc G Guedon; Michael B Yee; Mingdi Zhang; Stephen A K Harvey; William F Goins; Paul R Kinchington
Journal:  Virology       Date:  2015-04-11       Impact factor: 3.616

4.  Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children.

Authors:  Anne A Gershon; Jason Chen; Larry Davis; Clarissa Krinsky; Robert Cowles; Ross Reichard; Michael Gershon
Journal:  Trans Am Clin Climatol Assoc       Date:  2012

5.  Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models.

Authors:  Paul R Kinchington; William F Goins
Journal:  J Neurovirol       Date:  2011-12-28       Impact factor: 3.739

6.  Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus infection.

Authors:  Katherine S Lee; Wenbo Zhou; Jonah J Scott-McKean; Kaitlin L Emmerling; Guang-yun Cai; David L Krah; Alberto C Costa; Curt R Freed; Myron J Levin
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

7.  In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency.

Authors:  Tomohiko Sadaoka; Daniel P Depledge; Labchan Rajbhandari; Arun Venkatesan; Judith Breuer; Jeffrey I Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-12       Impact factor: 12.779

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.